InvestorsHub Logo
Followers 65
Posts 10321
Boards Moderated 3
Alias Born 06/30/2004

Re: jonesieatl post# 140450

Monday, 04/14/2008 9:52:41 PM

Monday, April 14, 2008 9:52:41 PM

Post# of 326352
George O'leary gets even busier ....

.... taking on BOD duties at yet another Yorkville client.

Does that mean he's done with us? Or that we are done?

Excerpt below taken from the most recent 10-Q for Isonics:

http://www.sec.gov/Archives/edgar/data/1023966/000110465908017359/a08-8057_110q.htm

Interesting that NeoGenomics is the only other of GO/YAGI clients that is mentioned. Also , YAGI is referred to by Isonics as "The holder of our 13% Debentures" a whole lot of times, rather than just saying "YA Global".

"Item 5: Other Information

On February 28, 2008 our Board of Directors unanimously appointed George O’Leary to fill one of the vacancies on our Board of Directors. Mr. O’Leary accepted his appointment on March 10, 2008. Upon acceptance of his appointment, Mr. O’Leary was not appointed to any committees of the Board of Directors, however in the future we may determine it is appropriate to do so.

There is no arrangement or understanding pursuant to which Mr. O’Leary was appointed to our Board of Directors. Mr. O’Leary has not had a direct or indirect interest in any of our previous transactions. Upon his appointment, Mr. O’Leary was not granted stock options or any other form of remuneration, however in the future we may determine it is appropriate to grant Mr. O’Leary stock options in consideration for his service as a Board member.

Mr. O’Leary currently serves as a director of several other companies including NeoGenomics, Inc. (NGNM.OB), a publicly traded cancer genetic testing laboratory. The holder of our 13% Debentures (YA Global f/k/a Cornell) has a business relationship with, and has previously invested in NeoGenomics, Inc. Our Board of Directors has considered the potential conflict of interest of Mr. O’Leary concurrently serving on our Board of Directors and other companies that have or had a business relationship with the holder of our 13% Debentures, and has determined that any such relationships will not interfere with Mr. O’Leary being able to faithfully carry out his duties as a member of our Board of Directors."